Organic electroluminescent materials and devices

US2018375035A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018375035-A1
Application numberUS-201816009455-A
CountryUS
Kind codeA1
Filing dateJun 15, 2018
Priority dateJun 23, 2017
Publication dateDec 27, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A compound comprising a first ligand L A of Formula I is provided. In Formula I, A is a 5- or 6-membered aryl or heteroaryl ring; each of Z 1 -Z 11 is either C or N; each of Y 1 -Y 4 is selected from a direct bond, BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′; at least one of Y 1 and Y 2 is not a direct bond; at least one of Y 3 and Y 4 is not a direct bond; each R A , R B , R C , R, and R′ is independently hydrogen or a variety of substituents; any two adjacent substitutions in R A , R B and R C can be joined or fused into a ring; ligand L A is coordinated to a metal M; L A is optionally linked with other ligands; and M is optionally coordinated to other ligands. Organic light emitting devices and consumer products containing the compounds are also disclosed.

First claim

Opening claim text (preview).

We claim: 1 . A metal-containing compound comprising a first ligand L A of Formula I wherein A is a 5- or 6-membered aryl or heteroaryl ring; wherein R A , R B , and R C each represent mono to a maximum possible number of substitutions, or no substitution; wherein Z 1 -Z 11 are each independently selected from the group consisting of C and N; wherein Y 1 , Y 2 , Y 3 , and Y 4 are each independently selected from the group consisting of a direct bond, BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′; wherein at least one of Y 1 and Y 2 is not a direct bond; wherein at least one of Y 3 and Y 4 is not a direct bond; wherein R A , R B , R C , R, and R′ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent substitutions in R A , R B and R C are optionally joined or fused into a ring; wherein the ligand L A is coordinated to a metal M; wherein L A is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein M is optionally coordinated to other ligands. 2 . The compound of claim 1 , wherein one of Y 1 and Y 2 is O and the other one of Y 1 and Y 2 is a direct bond, and one of Y 3 and Y 4 is O and the other one of Y 3 and Y 4 is a direct bond, or wherein one of Y 1 and Y 2 is S and the other one of Y 1 and Y 2 is a direct bond, and one of Y 3 and Y 4 is S and the other one of Y 3 and Y 4 is a direct bond. 3 . The compound of claim 1 , wherein each of Y 1 , Y 2 , Y 3 , and Y 4 is O or each of Y 1 , Y 2 , Y 3 , and Y 4 is S. 4 . The compound of claim 1 , wherein Z 1 is N, Z 2 is C, and Z 3 is C. 5 . The compound of claim 1 , wherein Z 1 is C, Z 2 is N, and Z 3 is C. 6 . The compound of claim 1 , wherein Z 1 is N, Z 2 is C, and Z 3 is N. 7 . The compound of claim 1 , wherein each one of Z 4 through Z 11 is C. 8 . The compound of claim 1 , wherein at least one of Z 4 through Z 11 is N. 9 . The compound of claim 1 , wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 10 . The compound of claim 1 , wherein ring A is selected from the group consisting of pyridine, pyrimidine, imidazole, pyrazole, and imidazole derived carbene. 11 . The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of: wherein each of Z 12 through Z 14 is independently selected from the group consisting of C and N; wherein R D is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substitutions of R A , R B , R C , and R D are optionally joined or fused into a ring. 12 . The compound of claim 1 , wherein ring A is pyridine, Z 1 is nitrogen, and R A para to Z 1 is not hydrogen or deuterium. 13 . The compound of claim 1 , wherein R A is at least a monosubstitution and at least one of R A substituent is selected from the group consisting of: 14 . The compound of claim 1 , wherein L A is selected from the group consisting of L A1 to L A544 , which are defined as follows: Ligand L A1 through L A5 , each represented by the formula wherein in ligand L A1 , Y 1 = O, Y 4 = O; in ligand L A2 , Y 1 = S, Y 4 = S; in ligand L A3 , Y 1 = C(CH 3 ) 2 , Y 4 = C(CH 3 ) 2 ; in ligand L A4 , Y 1 = O, Y 4 = S; in ligand L A5 , Y 1 = S, Y 4 = O; Ligand L A6 through L A10 , each represented by the formula wherein in ligand L A6 , Y 1 = O, Y 4 = O; in ligand L A7 , Y 1 = S, Y 4 = S; in ligand L A8 , Y 1 = C(CH 3 ) 2 , Y 4 = C(CH 3 ) 2 ; in ligand L A9 , Y 1 = O, Y 4 = S; in ligand L A10 , Y 1 = S, Y 4 = O; Ligand L A11 through L A15 , each represented by the formula

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018375035A1 cover?
A compound comprising a first ligand L A of Formula I is provided. In Formula I, A is a 5- or 6-membered aryl or heteroaryl ring; each of Z 1 -Z 11 is either C or N; each of Y 1 -Y 4 is selected from a direct bond, BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′; at least one of Y 1 and Y…
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification H01L51/0085. Mapped technology areas include Electricity.
When was this patent published?
Publication date Thu Dec 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).